P/B
3,1
In spring 2024, 3M spun out its legacy healthcare segment as a stand-alone firm, Solventum. At that time, the firm comprised four segments. The smallest one—purification and filtration—has since been sold. Now, medsurg is the largest business, contributing roughly 64% of consolidated revenue, and includes advanced wound care and wound prevention. Dental solutions (restorative composites and orthodontia) and health information systems (mainly revenue cycle management) each contribute 18% of total revenue.
In spring 2024, 3M spun out its legacy healthcare segment as a stand-alone firm, Solventum. At that time, the firm comprised four segments. The smallest one—purification and filtration—has since been sold. Now, medsurg is the largest business, contributing roughly 64% of consolidated revenue, and includes advanced wound care and wound prevention. Dental solutions (restorative composites and orthodontia) and health information systems (mainly revenue cycle management) each contribute 18% of total revenue.
$15B
Market Cap • 10/2/2026
2023
(3 years)
Founded
2024
(2 years ago)
IPO
NYSE
Listing Exchange
United States
Country
S&P500 Participant
Index Composite • 2026
Valuation
P/S
1,8
P/EBITDA
5,8
P/OCF
71,6
P/FCF
—
P/E
10,7
BVPS
28,2
EPS
8,2
Market Cap
Market Cap
15B
EV
19,8B
EV/Revenue
2,4
EV/EBITDA
7,7
EV/EBIT
9,6
Payout
Dividend Per Share
0
Dividend Yield
0%
Buyback Yield
0%
Total Yield
0%
Payout
0%
Retained Earnings
1,9B
Profitability
Gross Margin
54,7%
EBITDA Margin
31,1%
EBIT Margin
25%
Net Margin
17,3%
D&A/EBITDA
0%
R&D/Revenue
8,7%
Capex/Revenue
3,9%
Capex/D&A
64,6%
Capex/OCF
156,5%
SBC/OCF
79,9%
% PPE
11%
% Goodwill
39,5%
ROE
34%
ROIC
15,3%
Leverage
N.D./EBITDA
1,9
Debt/Equity
0%
Current Ratio
1
Quick Ratio
0,5
Interest Coverage
780,5%
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!